Patients taking oral doses of perhexiline maleate have been examined. Measurement of serum perhexiline concentrations established that different dose requirements between patients were necessary due to the different doses at which drug saturation was achieved. Measurement of serum perhexiline concentrations are essential if side-effects from the drug are to be avoided.
References
1.
PitcherJChandrasekharKPReesJ RussellLong term assessment of perhexiline maleate in angina pectoris. Postgrad Med J1973; April (Suppl) 115–18.
2.
Burns-CoxCJChandrasekharKPIkramHClinical evaluation of perhexiline maleate in patients with angina pectoris. Br Med J1971; 4: 586–8.
3.
BeaugrandMPouponRLevyVGHepatic lesions due to perhexiline maleate. Gastroenterol Clin Biol1978; 2: 579–88.
4.
L'HermitteFFardeauMChedruFMallecourtJ.Polyneuropathy after perhexiline maleate therapy. Br Med J1976; 1: 1256–8.
5.
SinglasEGoujetMASimonF.Pharmokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy. Eur J Clin Pharmacol1978; 14: 195–201.
6.
ShahRROatesNSIdleJRSmithRLLockhartJDF.Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br Med J1982; 284: 295–9.
7.
CooperJDHTurnellDC.A rapid method for the determination of perhexiline in serum using gas—liquid chromatography. Ann Clin Biochem1980; 17: 155–8.
8.
PilcherJCooperJDHTurnellDCInvestigations of long term treatment with perhexiline maleate using therapeutic monitoring and electromyography. Therapeutic Drug Monitoring1985; 7: 54–60.
